oxazoles has been researched along with Bacterial Pneumonia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broyde, N; Butterton, JR; Croce, M; De Anda, C; Fujimi, S; Kim, JY; Popejoy, MW; Rodriguez Gonzalez, D; Roquilly, A; Wunderink, RG | 1 |
| Chen, KH; Hsueh, PR; Huang, YT; Liao, CH; Sheng, WH | 1 |
| Cao, B; Chen, H; Chu, Y; Du, Y; Feng, X; Fu, Q; Gui, Q; Guo, Y; Hu, B; Hu, Y; Hu, Z; Ji, P; Jia, W; Jin, Y; Lei, JE; Li, S; Liao, K; Liu, Z; Ni, Y; Wang, H; Wang, Z; Xu, X; Yang, Q; Yu, Y; Zeng, J; Zhang, R; Zhang, Z; Zhao, C; Zhuo, C | 1 |
| Hashiguchi, S; Iizawa, Y; Ishikawa, T; Miyake, A; Nagai, J; Nakao, M; Okonogi, K | 1 |
| Andes, D; Craig, WA | 1 |
1 trial(s) available for oxazoles and Bacterial Pneumonia
| Article | Year |
|---|---|
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Topics: Anti-Bacterial Agents; Double-Blind Method; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Pneumonia, Bacterial; Skin Diseases, Bacterial; Ventilators, Mechanical | 2021 |
4 other study(ies) available for oxazoles and Bacterial Pneumonia
| Article | Year |
|---|---|
In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Topics: Acute Disease; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus agalactiae; Streptococcus anginosus; Streptococcus pyogenes; Taiwan; Vancomycin-Resistant Enterococci | 2015 |
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.
Topics: Anti-Bacterial Agents; China; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections | 2016 |
In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.
Topics: Animals; Butyrates; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterococcus; Male; Methicillin Resistance; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazoles; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus | 2004 |
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
Topics: Animals; Butyrates; Female; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazoles; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2006 |